Literature DB >> 17380422

Pharmacists' changing views of their supplementary prescribing authority.

Mary P Tully1, Saima Latif, Judith A Cantrill, Dianne Parker.   

Abstract

OBJECTIVE: To investigate the views and experiences of pharmacists in England before and after they registered as supplementary prescribers.
METHOD: Eight pharmacists were recruited from training courses; seven from secondary care and one from primary care and interviewed during training and again after registration. In the first interviews, topics included previous experience, views on current roles, responsibilities and accountability for prescribing and how these might change. In the second interviews, the pharmacists discussed how these had actually changed after gaining supplementary prescribing authority, how their role worked in practice and how they saw it developing in the future. MAIN OUTCOME MEASURE: Descriptions of anticipated and actual changes in their roles, responsibilities and accountability before and after registration as supplementary prescribers
RESULTS: The pharmacists anticipated that training would legitimise their current 'informal' prescribing practices, with increased legal responsibility and accountability, but experienced many procedural delays in implementing their new role. Pharmacists who were already heavily involved with prescribing were more likely to work as prescribers, but not necessarily within the clinical management plan framework. The desire to maintain the efficiency of their existing clinical services impacted negatively on the pharmacists' ability or willingness to prescribe in this legally approved manner.
CONCLUSION: Clear and realistic expectations need to be set by the pharmacists as to what is achievable and greater attention needs to be paid to minimising delays between the end of training and the beginning of practice, to minimise reduction in motivation and redeployment of staff.

Mesh:

Year:  2007        PMID: 17380422     DOI: 10.1007/s11096-007-9114-2

Source DB:  PubMed          Journal:  Pharm World Sci        ISSN: 0928-1231


  7 in total

Review 1.  Impact of pharmacists providing a prescription review and monitoring service in ambulatory care or community practice.

Authors:  M P Tully; E M Seston
Journal:  Ann Pharmacother       Date:  2000-11       Impact factor: 3.154

2.  Value of community pharmacists' interventions to correct prescribing errors.

Authors:  M T Rupp
Journal:  Ann Pharmacother       Date:  1992-12       Impact factor: 3.154

3.  The New Deal: an account of progress in reducing junior hospital doctors' hours in England.

Authors:  P Loveland
Journal:  Health Trends       Date:  1992

4.  Supplementary prescribing: early experiences of pharmacists in Great Britain.

Authors:  Johnson George; Dorothy J McCaig; Christine M Bond; I T Scott Cunningham; H Lesley Diack; Anne M Watson; Derek C Stewart
Journal:  Ann Pharmacother       Date:  2006-09-12       Impact factor: 3.154

5.  Repeat prescribing: a role for community pharmacists in controlling and monitoring repeat prescriptions.

Authors:  C Bond; C Matheson; S Williams; P Williams; P Donnan
Journal:  Br J Gen Pract       Date:  2000-04       Impact factor: 5.386

6.  Effect of computerized physician order entry and a team intervention on prevention of serious medication errors.

Authors:  D W Bates; L L Leape; D J Cullen; N Laird; L A Petersen; J M Teich; E Burdick; M Hickey; S Kleefield; B Shea; M Vander Vliet; D L Seger
Journal:  JAMA       Date:  1998-10-21       Impact factor: 56.272

7.  Collaborative drug therapy management by pharmacists--2003.

Authors:  Raymond W Hammond; Amy H Schwartz; Marla J Campbell; Tami L Remington; Susan Chuck; Melissa M Blair; Ann M Vassey; Raylene M Rospond; Sheryl J Herner; C Edwin Webb
Journal:  Pharmacotherapy       Date:  2003-09       Impact factor: 4.705

  7 in total
  7 in total

1.  Evaluating the labour costs associated with pharmacy adaptation services in British Columbia.

Authors:  Carlo A Marra; Larry D Lynd; Kelly A Grindrod; Pamela Joshi; Alana Isakovic
Journal:  Can Pharm J (Ott)       Date:  2012-03

2.  Stakeholders' views and experiences of pharmacist prescribing: a systematic review.

Authors:  Tesnime Jebara; Scott Cunningham; Katie MacLure; Ahmed Awaisu; Abdulrouf Pallivalapila; Derek Stewart
Journal:  Br J Clin Pharmacol       Date:  2018-06-19       Impact factor: 4.335

3.  Improving hypertension management through pharmacist prescribing; the rural Alberta clinical trial in optimizing hypertension (Rural RxACTION): trial design and methods.

Authors:  Theresa L Charrois; Finlay A McAlister; Dale Cooney; Richard Lewanczuk; Michael R Kolber; Norman Rc Campbell; Meagen Rosenthal; Sherilyn Kd Houle; Ross T Tsuyuki
Journal:  Implement Sci       Date:  2011-08-11       Impact factor: 7.327

4.  Classic e-Delphi survey to provide national consensus and establish priorities with regards to the factors that promote the implementation and continued development of non-medical prescribing within health services in Wales.

Authors:  Molly Courtenay; Rhian Deslandes; Gail Harries-Huntley; Karen Hodson; Gary Morris
Journal:  BMJ Open       Date:  2018-09-19       Impact factor: 2.692

5.  Learning to prescribe - pharmacists' experiences of supplementary prescribing training in England.

Authors:  Richard J Cooper; Joanne Lymn; Claire Anderson; Anthony Avery; Paul Bissell; Louise Guillaume; Allen Hutchinson; Elizabeth Murphy; Julie Ratcliffe; Paul Ward
Journal:  BMC Med Educ       Date:  2008-12-05       Impact factor: 2.463

6.  Factors influencing pharmacists' adoption of prescribing: qualitative application of the diffusion of innovations theory.

Authors:  Mark J Makowsky; Lisa M Guirguis; Christine A Hughes; Cheryl A Sadowski; Nese Yuksel
Journal:  Implement Sci       Date:  2013-09-14       Impact factor: 7.327

7.  A theoretically informed, mixed-methods study of pharmacists' aspirations and readiness to implement pharmacist prescribing.

Authors:  Derek Stewart; Abdulrouf Pallivalapila; Binny Thomas; Yolande Hanssens; Wessam El Kassem; Zachariah Nazar; Moza Al Hail
Journal:  Int J Clin Pharm       Date:  2021-06-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.